Oral Wegovy 25mg: The Complete Patient Guide

The first GLP-1 pill for weight loss launched in January 2026. Here's everything patients need to know about oral Wegovy — dosing, cost, efficacy, and how it compares to injectables.

What Is Oral Wegovy?

Oral Wegovy is a once-daily semaglutide tablet approved for chronic weight management and cardiovascular risk reduction. It contains the same active ingredient as injectable Wegovy and Ozempic, but in a pill formulation that absorbs through the stomach lining.

Available in four strengths: 1.5mg, 4mg, 9mg, and 25mg tablets. The target maintenance dose is 25mg daily, reached after a 12-week dose escalation period.

OASIS 4 Trial Results

The pivotal trial enrolled 307 adults with obesity or overweight (plus at least one weight-related condition, without diabetes). Results at 64 weeks:

Outcome	Oral Semaglutide 25mg	Placebo
Mean weight loss (adherent)	16.6%	2.7%
Mean weight loss (all patients)	13.6%	2.4%
Achieved ≥5% weight loss	76.3%	31.3%
Achieved ≥10% weight loss	~60%	~15%
Achieved ≥20% weight loss	34.4%	2.9%

Additional findings included improvements in blood pressure, cholesterol, triglycerides, and waist circumference. Over 70% of participants with prediabetes at baseline normalized their blood glucose levels.

How to Take It

Oral semaglutide has specific dosing requirements that affect its absorption:

• Take on an empty stomach — first thing in the morning works best
• Swallow with no more than 4 oz of plain water
• Wait at least 30 minutes before eating, drinking, or taking other medications
• Do not crush, chew, or split the tablet

The 30-minute fasting requirement is the most significant practical difference from injectable formulations. The pill uses a specialized absorption enhancer (SNAC) that requires an empty stomach to work effectively.

Dose Escalation Schedule

Weeks	Daily Dose	Purpose
1-4	1.5mg	Initiation — allow GI tolerance
5-8	4mg	Escalation 1
9-12	9mg	Escalation 2
13+	25mg	Target maintenance dose

Oral vs Injectable: Which Is Right for You?

	Oral Wegovy (25mg daily)	Injectable Wegovy (2.4mg weekly)
Frequency	Once daily	Once weekly
Needles	None	Auto-injector pen
Refrigeration	Not required	Required (36-46°F)
Food restriction	30 min empty stomach	None
Self-pay cost	$149/month	$349/month+
Weight loss	~16.6%	~15%
Travel convenience	High — no cold chain	Moderate — needs refrigeration

Side Effects

Side effects are consistent with injectable semaglutide:

• Most common: Nausea, diarrhea, vomiting — typically most pronounced during dose escalation
• GI management: Eating smaller meals, avoiding fatty foods, and staying hydrated can reduce severity
• Boxed warning: Risk of thyroid C-cell tumors — discuss with your provider

Who Should Consider Oral Wegovy

• Adults with BMI ≥30, or ≥27 with a weight-related condition
• People who want to avoid injections
• Patients looking for the most affordable brand-name GLP-1 option
• Those who travel frequently (no refrigeration needed)

Alternative Provider Options

The Bottom Line

Oral Wegovy represents a significant expansion of GLP-1 access — the first weight-loss pill in this class, at a price point ($149/month) that undercuts many compounded alternatives. The 16.6% weight loss with full adherence matches the injectable. The trade-off is daily dosing with a 30-minute fasting requirement. For patients who've avoided GLP-1 treatment due to needle aversion or cost, oral Wegovy removes both barriers.